Aclarion (ACON) Return on Invested Capital (ROIC)

Price: $0.7563
Market Cap: $768.32K
Avg Volume: 5.40M
Country: US
Industry: Medical - Healthcare Information Services
Sector: Healthcare
Beta: 0.469
52W Range: $0.61-231.15
Website: Aclarion

Return on Invested Capital (ROIC) Summary

Aclarion's ROIC measures how effectively the company uses its invested capital to generate profits:

  • Annual: -1225.96%
  • Quarterly: -51.64%
  • TTM: -192.57%

What is ROIC?

Return on Invested Capital (ROIC) measures how effectively a company uses its capital from debt and equity to generate profits. ROIC is a useful metric for comparing the efficiency of capital allocation between different companies or across time periods within the same company. A higher ROIC indicates a more efficient use of capital.

Related Metrics

Other important metrics to assess Aclarion's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: 674.64%
    • Quarterly: -54.43%
    • TTM: -422.89%
  • ROA (Return on Assets) - measures the return generated on the company's assets:
    • Annual: -199.67%
    • Quarterly: -42.85%
    • TTM: -196.63%

These metrics provide insights into Aclarion's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROIC

-1225.96%

Quarterly ROIC

-51.64%

TTM ROIC

-192.57%

Aclarion Historical ROIC

Historical ROE

Historical ROA

Aclarion Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.

Year ROIC ROE ROA
2023 -1225.96% 674.64% -199.67%
2022 -408.69% -509.68% -284.21%
2021 56.54% 61.69% -187.07%
2020 98.31% 67.63% -370.84%
2019 338.69% 236.44% -281.33%

Related Metrics

Explore detailed financial metrics and analysis for ACON.